The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


AirFluSal Forspiro 50 microgram/500 microgram/dose, inhalation powder, predispensed



Lexon Pharmaceuticals (Ireland) LimitedPPA23176/004/002

Main Information

Trade NameAirFluSal Forspiro 50 microgram/500 microgram/dose, inhalation powder, predispensed
Active SubstancesSALMETEROL XINAFOATE
FLUTICASONE PROPIONATE
Dosage FormInhalation powder, pre-dispensed
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/004/002

Group Information

ATC CodeR03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
R03AK06 salmeterol and fluticasone

Status

Authorised/WithdrawnAuthorised
Licence Issued19/05/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back